Europe — EMA

Oxaliplatin Fresenius Kabi Deutschland

Oxaliplatin, the active ingredient in Oxaliplatin Fresenius Kabi Deutschland, is a platinum compound presented as a sterile injectable solution for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Fresenius Kabi Deutschland, is a platinum compound presented as a sterile injectable solution for intravenous use. It is employed in the treatment of colorectal cancer, typically administered to adult patients undergoing combination chemotherapy regimens. GNH USA supplies Oxaliplatin Fresenius Kabi Deutschland as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres and hospitals worldwide.

What is Oxaliplatin used for?

Oxaliplatin is an antineoplastic agent used primarily for cancers of the gastrointestinal tract. - Colorectal cancer: Enhances the efficacy of fluoropyrimidine‑based regimens by inducing DNA cross‑links that prevent tumor cell proliferation. - Gastric cancer: Used in combination with other chemotherapy agents to improve response rates and survival. - Pancreatic but but but but but ...

What are the side effects of Oxaliplatin?

The

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →